nach oben

Reactions Weekly

Erschienen in:

01.03.2024 | Case report

Furosemide/immune-globulin

Lack of efficacy and off-label use

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Case 1 (A 27-day-old girl), has been adressed as 'he' at once instance. However, at two other instances, the patient has been adressed as 'she'. Hence, the patient has been considered as 'girl'.

Maharlouei N, et al. Incidence, Clinical Features, and Outcomes of the Confirmed Neonatal COVID-19 Infection in the Southwest Iran. International Journal of Pediatrics 2023: Jan 2023. Available from: URL: https://dx.doi.org/10.1155/2023/7095326

Titel: Furosemide/immune-globulin
Lack of efficacy and off-label use
Publikationsdatum: 01.03.2024
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-53768-x

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Furosemide/immune-globulin

Lack of efficacy and off-label use

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Multiple drugs

Multiple drugs

Other adverse reaction research

Eculizumab/Quinine

Remdesivir/sotrovimab

Regorafenib